{"transactions":[{"id":2651747,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T19:42:09.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is 25% vested upon grant with the remaining 75% vesting in equally in quarterly installments over the next two years."}],"balance_after":33000,"derivative":{"exercise_price":3.16,"exercise_date":"2021-06-28","expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001493152-21-015620","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000149315221015620/ownership.xml","form_type":"4"}},{"id":2651746,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2021-06-29T19:42:09.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":13613,"price":3.16,"value":43017.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the vesting of 48,000 RSUs on June 28, 2021, a total of 13,613 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."}],"balance_after":178387,"source":{"system":"sec-edgar","filing":"0001493152-21-015620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000149315221015620/ownership.xml","form_type":"4"}},{"id":2651745,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2021-06-29T19:42:09.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":192000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted stock units (RSUs) that were 25% vested upon grant with the remaining 75% vesting in equal quarterly installments over the next two years."}],"balance_after":192000,"source":{"system":"sec-edgar","filing":"0001493152-21-015620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000149315221015620/ownership.xml","form_type":"4"}},{"id":2854679,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option(Right to Buy)","published_at":"2021-02-17T17:05:21.000Z","date":"2021-02-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option was 25% vested on February 2, 2021 and the remaining options vest quarterly over a two-year period."}],"balance_after":150000,"derivative":{"exercise_price":7.45,"exercise_date":"2021-02-02","expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-21-004162","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000149315221004162/ownership.xml","form_type":"4"}},{"id":3590598,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2019-03-18T17:44:44.000Z","date":"2019-03-15","kind":"exercise","acquired":false,"shares":169032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":169032},"source":{"system":"sec-edgar","filing":"0001127602-19-011924","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760219011924/form4.xml","form_type":"4"}},{"id":3590597,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-18T17:44:44.000Z","date":"2019-03-15","kind":"exercise","acquired":true,"shares":169032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."}],"balance_after":239268,"source":{"system":"sec-edgar","filing":"0001127602-19-011924","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760219011924/form4.xml","form_type":"4"}},{"id":3843348,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2018-08-15T07:43:26.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":169032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest."}],"balance_after":169032,"derivative":{"underlying":"Common Stock","underlying_shares":169032},"source":{"system":"sec-edgar","filing":"0001127602-18-025357","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760218025357/form4.xml","form_type":"4"}},{"id":3887199,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right To Purchase)","published_at":"2018-06-20T16:22:01.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":338068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These options expire on the third anniversary of the vesting date."}],"balance_after":338068,"derivative":{"exercise_price":1.1,"underlying":"Common Stock","underlying_shares":338068},"source":{"system":"sec-edgar","filing":"0001127602-18-021574","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760218021574/form4.xml","form_type":"4"}},{"id":4015483,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right To Purchase)","published_at":"2018-03-05T08:19:17.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, representing a right to purchase a total of 280,000 shares of Common Stock, will become exercisable on March 1, 2019, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":280000,"derivative":{"exercise_price":14.98,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001127602-18-009804","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760218009804/form4.xml","form_type":"4"}},{"id":4015482,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-05T08:19:17.000Z","date":"2018-03-02","kind":"sale","acquired":false,"shares":2500,"price":15.08,"value":37700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.79 to $15.31 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":70236,"source":{"system":"sec-edgar","filing":"0001127602-18-009804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760218009804/form4.xml","form_type":"4"}},{"id":4015481,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-05T08:19:17.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":2500,"price":14.81,"value":37025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.44 to $15.29 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":72736,"source":{"system":"sec-edgar","filing":"0001127602-18-009804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760218009804/form4.xml","form_type":"4"}},{"id":4037118,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-23T17:28:13.000Z","date":"2018-02-23","kind":"sale","acquired":false,"shares":2500,"price":15.37,"value":38425.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.92 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":75236,"source":{"system":"sec-edgar","filing":"0001127602-18-008091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760218008091/form4.xml","form_type":"4"}},{"id":4037117,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-23T17:28:13.000Z","date":"2018-02-22","kind":"sale","acquired":false,"shares":2500,"price":15.47,"value":38675.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.75 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":77736,"source":{"system":"sec-edgar","filing":"0001127602-18-008091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760218008091/form4.xml","form_type":"4"}},{"id":4079269,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-02T21:15:55.000Z","date":"2018-02-02","kind":"sale","acquired":false,"shares":2500,"price":12.96,"value":32400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $12.78 to $13.06 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":80236,"source":{"system":"sec-edgar","filing":"0001127602-18-003874","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760218003874/form4.xml","form_type":"4"}},{"id":4079268,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-02T21:15:55.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":2500,"price":13.14,"value":32850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $12.68 to $13.45 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":82736,"source":{"system":"sec-edgar","filing":"0001127602-18-003874","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760218003874/form4.xml","form_type":"4"}},{"id":4112348,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-03T18:48:14.000Z","date":"2018-01-03","kind":"sale","acquired":false,"shares":2500,"price":10.11,"value":25275.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.21 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":85236,"source":{"system":"sec-edgar","filing":"0001127602-18-000813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760218000813/form4.xml","form_type":"4"}},{"id":4112347,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-03T18:48:14.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":2500,"price":10.11,"value":25275.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.45 to $10.45 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":87736,"source":{"system":"sec-edgar","filing":"0001127602-18-000813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760218000813/form4.xml","form_type":"4"}},{"id":4142107,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-12-05T17:39:56.000Z","date":"2017-12-05","kind":"sale","acquired":false,"shares":2500,"price":9.68,"value":24200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.46 to $9.87 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":90236,"source":{"system":"sec-edgar","filing":"0001127602-17-033971","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217033971/form4.xml","form_type":"4"}},{"id":4142106,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-12-05T17:39:56.000Z","date":"2017-12-04","kind":"sale","acquired":false,"shares":2500,"price":9.97,"value":24925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.70 to $10.37 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":92736,"source":{"system":"sec-edgar","filing":"0001127602-17-033971","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217033971/form4.xml","form_type":"4"}},{"id":4142105,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-12-05T17:39:56.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":2500,"price":9.92,"value":24800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.70 to $10.06 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":95236,"source":{"system":"sec-edgar","filing":"0001127602-17-033971","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217033971/form4.xml","form_type":"4"}},{"id":4172809,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-03T17:53:44.000Z","date":"2017-11-03","kind":"sale","acquired":false,"shares":2500,"price":10.86,"value":27150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.62 to $11.02 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":97736,"source":{"system":"sec-edgar","filing":"0001127602-17-031249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217031249/form4.xml","form_type":"4"}},{"id":4172808,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-03T17:53:44.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":2500,"price":10.94,"value":27350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.70 to $11.08 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100236,"source":{"system":"sec-edgar","filing":"0001127602-17-031249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217031249/form4.xml","form_type":"4"}},{"id":4172807,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-03T17:53:44.000Z","date":"2017-11-01","kind":"sale","acquired":false,"shares":2500,"price":10.92,"value":27300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.74 to $11.40 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":102736,"source":{"system":"sec-edgar","filing":"0001127602-17-031249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217031249/form4.xml","form_type":"4"}},{"id":4192222,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-10-04T17:52:49.000Z","date":"2017-10-04","kind":"sale","acquired":false,"shares":2500,"price":11.14,"value":27850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $11.07 to $11.22 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":105236,"source":{"system":"sec-edgar","filing":"0001127602-17-029259","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217029259/form4.xml","form_type":"4"}},{"id":4192221,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-10-04T17:52:49.000Z","date":"2017-10-03","kind":"sale","acquired":false,"shares":2500,"price":10.93,"value":27325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.77 to $11.09 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":107736,"source":{"system":"sec-edgar","filing":"0001127602-17-029259","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217029259/form4.xml","form_type":"4"}},{"id":4192220,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-10-04T17:52:49.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":2500,"price":10.81,"value":27025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.70 to $10.90 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":110236,"source":{"system":"sec-edgar","filing":"0001127602-17-029259","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217029259/form4.xml","form_type":"4"}},{"id":4216104,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-09-06T20:01:51.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":2500,"price":10.31,"value":25775.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.03 to $10.56 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":112736,"source":{"system":"sec-edgar","filing":"0001127602-17-027107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217027107/form4.xml","form_type":"4"}},{"id":4216103,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-09-06T20:01:51.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":2500,"price":9.94,"value":24850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.81 to $10.18 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":115236,"source":{"system":"sec-edgar","filing":"0001127602-17-027107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217027107/form4.xml","form_type":"4"}},{"id":4216102,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-09-06T20:01:51.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":2500,"price":10.37,"value":25925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.14 to $10.60 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":117736,"source":{"system":"sec-edgar","filing":"0001127602-17-027107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217027107/form4.xml","form_type":"4"}},{"id":4243714,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-08-03T20:45:07.000Z","date":"2017-08-03","kind":"sale","acquired":false,"shares":2500,"price":10.4,"value":26000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.16 to $10.61 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120236,"source":{"system":"sec-edgar","filing":"0001127602-17-024929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217024929/form4.xml","form_type":"4"}},{"id":4243713,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-08-03T20:45:07.000Z","date":"2017-08-02","kind":"sale","acquired":false,"shares":2500,"price":10.53,"value":26325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.41 to $10.72 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":122736,"source":{"system":"sec-edgar","filing":"0001127602-17-024929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217024929/form4.xml","form_type":"4"}},{"id":4243712,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-08-03T20:45:07.000Z","date":"2017-08-01","kind":"sale","acquired":false,"shares":2500,"price":10.65,"value":26625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.54 to $10.85 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":125236,"source":{"system":"sec-edgar","filing":"0001127602-17-024929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217024929/form4.xml","form_type":"4"}},{"id":4261979,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-07-06T17:50:40.000Z","date":"2017-07-06","kind":"sale","acquired":false,"shares":2500,"price":10.08,"value":25200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.01 to $10.22 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":127736,"source":{"system":"sec-edgar","filing":"0001127602-17-023286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217023286/form4.xml","form_type":"4"}},{"id":4261978,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-07-06T17:50:40.000Z","date":"2017-07-05","kind":"sale","acquired":false,"shares":2500,"price":10.21,"value":25525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.10 to $10.33 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":130236,"source":{"system":"sec-edgar","filing":"0001127602-17-023286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217023286/form4.xml","form_type":"4"}},{"id":4261977,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-07-06T17:50:40.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":2500,"price":10.27,"value":25675.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.07 to $10.48 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":132736,"source":{"system":"sec-edgar","filing":"0001127602-17-023286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217023286/form4.xml","form_type":"4"}},{"id":4328347,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-05-09T15:33:30.000Z","date":"2017-04-26","kind":"sale","acquired":false,"shares":100,"price":11.1,"value":1110.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":135236,"source":{"system":"sec-edgar","filing":"0001127602-17-017360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217017360/form4.xml","form_type":"4"}},{"id":4384525,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Option (right To Purchase)","published_at":"2017-03-15T15:30:10.000Z","date":"2017-03-13","kind":"grant","acquired":true,"shares":267500,"price":8.86,"value":2370050.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 267,500 shares of Common Stock, will become exercisable on February 17, 2018, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":267500,"derivative":{"exercise_price":8.86,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":267500},"source":{"system":"sec-edgar","filing":"0001127602-17-011765","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217011765/form4.xml","form_type":"4"}},{"id":4461597,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-08T15:53:30.000Z","date":"2017-02-07","kind":"sale","acquired":false,"shares":1500,"price":9.52,"value":14280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.37 to $9.62 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":245479,"source":{"system":"sec-edgar","filing":"0001127602-17-004564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217004564/form4.xml","form_type":"4"}},{"id":4464143,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-07T16:12:43.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":1500,"price":9.52,"value":14280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.40 to $9.59 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":246979,"source":{"system":"sec-edgar","filing":"0001127602-17-004341","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217004341/form4.xml","form_type":"4"}},{"id":4464142,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-07T16:12:43.000Z","date":"2017-02-03","kind":"sale","acquired":false,"shares":1500,"price":9.69,"value":14535.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.60 to $9.82 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":248479,"source":{"system":"sec-edgar","filing":"0001127602-17-004341","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217004341/form4.xml","form_type":"4"}},{"id":4468763,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-03T15:25:50.000Z","date":"2017-02-02","kind":"sale","acquired":false,"shares":1500,"price":9.61,"value":14415.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.46 to $9.80 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":249979,"source":{"system":"sec-edgar","filing":"0001127602-17-003847","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217003847/form4.xml","form_type":"4"}},{"id":4468762,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-03T15:25:50.000Z","date":"2017-02-01","kind":"sale","acquired":false,"shares":1500,"price":9.38,"value":14070.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.16 to $9.63 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":251479,"source":{"system":"sec-edgar","filing":"0001127602-17-003847","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760217003847/form4.xml","form_type":"4"}},{"id":4535384,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-02T15:00:47.000Z","date":"2016-12-01","kind":"sale","acquired":false,"shares":7500,"price":11.6,"value":87000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $11.11 to $12.35 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":252979,"source":{"system":"sec-edgar","filing":"0001127602-16-068954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760216068954/form4.xml","form_type":"4"}},{"id":4587082,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":137779,"kind":"person","name":"Leuthner Brian A","position":1,"cik":"0001652973","reported_name":"Leuthner Brian A","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-10-04T11:16:44.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":7500,"price":10.2459,"value":76844.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.02 to $10.53 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":260479,"source":{"system":"sec-edgar","filing":"0001127602-16-063859","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652973/000112760216063859/form4.xml","form_type":"4"}}]}